Related references
Note: Only part of the references are listed.Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group
Pierre Blanchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Induction Chemotherapy Meta-Analysis in Head and Neck Cancer: Right Answer, Wrong Question
Arlene A. Forastiere et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Robert Haddad et al.
LANCET ONCOLOGY (2013)
Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy Outcome in patients with locally advanced head and neck cancer
J. O. Broemme et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2013)
Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck
D. Rades et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2013)
Survival of patients with head and neck cancer Impact of physical status and comorbidities
F. Sadat et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma Feasibility and tolerability in elderly and chemotherapy-ineligible patients
F. Alongi et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer
M. N. Duma et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
A. Paccagnella et al.
ANNALS OF ONCOLOGY (2010)
Pretreatment Prognostic Factors of Survival in Patients With Locally Advanced Nonmetastatic Squamous Cell Carcinoma of the Head and Neck Treated With Radiation Therapy With or Without Concurrent Chemotherapy
Branislav Jeremic et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German cancer society 95-06 prospective randomized trial
V Budach et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
DJ Adelstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
